Skip to main content

What's new

Nick Jonas, singer, actor, and advocate for people with diabetes, is launching The Global Movement for Time in Range, an educational ad campaign to raise awareness for Time in Range in partnership with Beyond Type 1, other diabetes nonprofits, and Dexcom. Learn about Nick’s experience with Time in Range and why he is launching this initiative now. Continue Reading »

A remote six-month clinical trial is recruiting 150 children between the ages of two to five whose families are interested in trying automated insulin delivery. The study will evaluate the use of automated insulin delivery in young children to see if it improves Time in Range and other health metrics. Continue Reading »

The latest innovations in diabetes technology have brought Time in Range (TIR) to the forefront of diabetes care. Read to learn about the most exciting TIR news from one of the biggest international diabetes conferences of the year, with a special focus on automated insulin delivery systems for kids, adults, and seniors. Continue Reading »

New results show that Vida Health’s digital diabetes coaching program led to meaningful reductions in A1C levels among people with type 2 diabetes, especially for those highly engaged with the program. Continue Reading »

From automated insulin delivery to therapeutic advances to glucose management during COVID-19, read our full coverage of one of the biggest international virtual diabetes conferences this year. Continue Reading »

The diaTribe team covers the latest in diabetes technology from the 14th annual ATTD 2021 international conference (set virtually this year). Here are our top highlights from day one – stay tuned for updates on the rest of the conference! Continue Reading »

Two diabetes devices from Medtronic – a next-gen continuous glucose monitor that removes fingerstick calibrations and a smart insulin delivery pen that keeps track of your insulin doses – will become available in Europe later this year. The two can share data with one another to simplify diabetes management for people on multiple daily injections of insulin. Continue Reading »

Bigfoot Biomedical’s new diabetes management system will provide insulin dosing recommendations based on glucose data and a healthcare professional’s instructions to people with diabetes who take multiple daily injections of insulin. Continue Reading »

Pages